These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3688636

  • 1. Effects of indomethacin on pulmonary hemodynamics and gas exchange in patients with pulmonary artery hypertension, interference with hydralazine.
    Adnot S, Defouilloy C, Brun-Buisson C, Piquet J, de Cremoux H, Lemaire F.
    Am Rev Respir Dis; 1987 Dec; 136(6):1343-9. PubMed ID: 3688636
    [Abstract] [Full Text] [Related]

  • 2. Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Corriveau ML, Shepard JW, Dolan GF.
    Am Rev Respir Dis; 1987 Jan; 135(1):118-22. PubMed ID: 3800141
    [Abstract] [Full Text] [Related]

  • 3. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Keller CA, Shepard JW, Chun DS, Dolan GF, Vasquez P, Minh VD.
    Am Rev Respir Dis; 1984 Oct; 130(4):606-11. PubMed ID: 6486560
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension.
    Adnot S, Kouyoumdjian C, Defouilloy C, Andrivet P, Sediame S, Herigault R, Fratacci MD.
    Am Rev Respir Dis; 1993 Aug; 148(2):310-6. PubMed ID: 8342892
    [Abstract] [Full Text] [Related]

  • 5. The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Adnot S, Andrivet P, Piquet J, Brun-Buisson C, Rauss A, Bignon J, Lemaire F.
    Am Rev Respir Dis; 1988 May; 137(5):1068-74. PubMed ID: 3143277
    [Abstract] [Full Text] [Related]

  • 6. Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension. A combined hemodynamic and radionuclide study.
    Tuxen DV, Powles AC, Mathur PN, Pugsley SO, Campbell EJ.
    Am Rev Respir Dis; 1984 Mar; 129(3):388-95. PubMed ID: 6322627
    [Abstract] [Full Text] [Related]

  • 7. Polycythemia impairs vasodilator response to acetylcholine in patients with chronic hypoxemic lung disease.
    Defouilloy C, Teiger E, Sediame S, Andrivet P, Roudot-Thoraval F, Chouaid C, Housset B, Adnot S.
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1452-60. PubMed ID: 9603123
    [Abstract] [Full Text] [Related]

  • 8. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease.
    Dal Nogare AR, Rubin LJ.
    Am Rev Respir Dis; 1986 Mar; 133(3):385-9. PubMed ID: 3954247
    [Abstract] [Full Text] [Related]

  • 9. Acute and long term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease.
    Johnson DC, Joshi RC, Mehta R, Cunnington AR.
    Eur J Respir Dis Suppl; 1986 Mar; 146():495-502. PubMed ID: 3465575
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
    Adnot S, Defouilloy C, Brun-Buisson C, Abrouk F, Piquet J, Lemaire F.
    Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E, Seoane M, Verdejo J.
    Chest; 1984 Feb; 85(2):156-63. PubMed ID: 6692695
    [Abstract] [Full Text] [Related]

  • 12. [Effects of nifedipine in patients with unstable chronic obstructive pulmonary disease].
    Seoane M, Verdejo J, Sandoval J, Lupi E.
    Arch Inst Cardiol Mex; 1986 Feb; 56(2):109-16. PubMed ID: 2942120
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E, Seoane M, Verdejo J, Gomez A, Sandoval J, Barrios R, Martinez W.
    Chest; 1985 May; 87(5):564-73. PubMed ID: 3987368
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase inhibition aggravates pulmonary hypertension and deteriorates gas exchange in canine pulmonary embolism.
    Delcroix M, Melot C, Lejeune P, Leeman M, Naeije R.
    Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):806-10. PubMed ID: 1554206
    [Abstract] [Full Text] [Related]

  • 18. Deleterious effects of hydralazine in patients with pulmonary hypertension.
    Packer M, Greenberg B, Massie B, Dash H.
    N Engl J Med; 1982 Jun 03; 306(22):1326-31. PubMed ID: 7070457
    [Abstract] [Full Text] [Related]

  • 19. Effects of captopril on hemodynamics and blood gases in chronic obstructive lung disease with pulmonary hypertension.
    Bertoli L, Lo Cicero S, Busnardo I, Rizzato G, Montanari G.
    Respiration; 1986 Jun 03; 49(4):251-6. PubMed ID: 3520734
    [Abstract] [Full Text] [Related]

  • 20. [Effects of captopril on hemodynamics, gas exchange and exercise capacity in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease].
    Paitl CE, Nery LE, Romaldini H, Herrmann JL, Portugal OP, dos Santos ML, Martinez Filho EE.
    Arq Bras Cardiol; 1989 Feb 03; 52(2):59-67. PubMed ID: 2688602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.